Thrivent Financial for Lutherans
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 314984
Minneapolis, MN
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,018,546
-$23,908,221 QoQ
Shares Held
20,169
-73.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#369
of 1,742 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $349,109,213 across 50 Biotechnology names. VRTX ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,620,743 | $88,184,625 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 3 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 5 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
20,169 | $10,018,546 | |
| 7 | VCEL |
Vericel Corp
|
170,272 | $7,575,400 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
17,229 | $6,403,502 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,018,546 | 20,169 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $33,926,767 | 75,977 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $34,766,816 | 76,687 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $30,653,661 | 78,270 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $39,267,529 | 88,202 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $42,219,579 | 87,083 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $34,767,890 | 87,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $42,636,207 | 91,675 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $44,431,842 | 94,794 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $37,189,093 | 88,967 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $24,968,802 | 61,365 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,299,922 | 75,631 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $36,322,740 | 103,216 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,055,246 | 73,175 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $27,485,214 | 95,177 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $27,597,215 | 95,314 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,185,835 | 103,573 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $27,368,445 | 104,872 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,508,357 | 52,406 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $8,044,646 | 44,350 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,942,492 | 44,351 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $9,544,124 | 44,414 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $99,459,433 | 420,832 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $108,073,273 | 397,153 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $125,948,670 | 433,842 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $116,352,314 | 488,978 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||